Patient-reported symptoms and quality of life integrated into clinical cancer care

Seminars in Oncology Nursing

Volumn 27, Issue 3, 2011, Pages 203-210

  Berry, Donna L ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cancer symptoms; Clinical informatics; Patient centered care; Patient reported outcomes; Quality of life

Indexed keywords

ARTICLE; DOCTOR PATIENT RELATION; HUMAN; NEOPLASM; PATHOPHYSIOLOGY; QUALITY OF LIFE; SELF DISCLOSURE;

HUMANS; NEOPLASMS; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE; SELF DISCLOSURE;

EID: 79960519827     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2011.04.005     Document Type: Article

References (80)

1. Doorenbos A.Z., Berger A.M., Brohard-Holbert C., et al. 2008 ONS research priorities survey. Oncol Nurs Forum 2008, 35:E100-E107.
2. Lyman G.H. Chemotherapy dose intensity and quality cancer care. Oncology (Williston Park) 2006, 20(suppl 9):16-25.
3. Paice J.A. Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr 2004, 32:98-102.
4. Faithfull S. 'Just grin and bear it and hope that it will go away': coping with urinary symptoms from pelvic radiotherapy. Eur J Cancer Care (Engl) 1995, 4:158-165.
5. Zabora J.R., Blanchard C.G., Smith E.D., et al. Prevalence of psychological distress among cancer patients across the disease continuum. J Psychosoc Oncol 1997, 15:73-87.
6. Pirl W.F., Roth A.J. Diagnosis and treatment of depression in cancer patients. Oncology (Williiston Park) 1999, 13:1293-1301. discussion 1301-1302, 1305-1306.
7. Kroenke K., Zhong X., Theobald D., et al. Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med 2010, 170:1686-1694.
8. Given C.W., Given B., Azzouz F., et al. Comparison of changes in physical functioning of elderly patients with new diagnoses of cancer. Med Care 2000, 38:482-493.
9. Page G.G., Ben-Eliyahu S. Pain kills: animal models and neuro-immunological links 1998, IASP Press, Seattle, WA.
10. Peterson D.E., Lalla R.V. Oral mucositis: the new paradigms. Curr Opin Oncol 2010, 22:318-322.
11. Back M., Guerrieri M., Wratten C., et al. Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. Clin Oncol (R Coll Radiol) 2004, 16:12-16.
12. Wujcik D. Infection. Cancer Symptom Management 1999, 307-327. Jones and Bartlett, Boston, MA. 3rd ed. C.H. Yarbro, M.H. Frogge, M. Goodman (Eds.).
13. Shafi M.A., Bresalier R.S. The gastrointestinal complications of oncologic therapy. Gastroenterol Clin North Am 2010, 39:629-647.
14. Ang K.K., Trotti A., Brown B.W., et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001, 51:571-578.
15. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003, 66:253-262.
16. Given B., Given C.W., McCorkle R., et al. Pain and fatigue management: results of a nursing randomized clinical trial. Oncol Nurs Forum 2002, 29:949-956.
17. Given C., Given B., Rahbar M., et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol 2004, 22:507-516.
18. Given C.W., Bradley C., You M., et al. Costs of novel symptom management interventions and their impact on hospitalizations. J Pain Symptom Manage 2010, 39:663-672.
19. Kurtz M.E., Kurtz J.C., Given C.W., et al. Effects of a symptom control intervention on utilization of health care services among cancer patients. Med Sci Monit 2006, 12:CR319-324.
20. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:1-24.
21. Yancik R., Wesley M.N., Ries L.A., et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 1998, 82:2123-2134.
22. Berry D.L., Ellis W.J., Schwien C.C., et al. Treatment decision making by men with localized prostate cancer: the influence of personal factors. Urol Oncol 2003, 21:93-100.
23. Fellowes D., Fallowfield L.J., Saunders C.M., et al. Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?. Breast Cancer Res Treat 2001, 66:73-81.
24. National Quality Forum. 2010; Available at: (accessed March 10, 2011). http://www.qualityforum.org.
25. Jacobsen P.B., Ransom S. Implementation of NCCN distress management guidelines by member institutions. J Natl Compr Canc Netw 2007, 5:99-103.
26. Braeken A.P., Lechner L., van Gils F.C., et al. The effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in cancer patients treated with radiotherapy: design of a cluster randomised controlled trial. BMC Cancer 2009, 9:177.
27. Velikova G., Brown J.M., Smith A.B., et al. Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 2002, 86:51-59.
28. Andersen B.L. Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol 1992, 60:552-568.
29. Cleeland C.S. Cancer-related symptoms. Semin Radiat Oncol 2000, 10:175-190.
30. Bruera E. Routine symptom assessment: good for practice and good for business. Support Care Cancer 2008, 16:537-538.
31. Levine M.N., Ganz P.A. Beyond the development of quality-of-life instruments: where do we go from here?. J Clin Oncol 2002, 20:2215-2216.
32. Taenzer P., Bultz B.D., Carlson L.E., et al. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psychooncology 2000, 9:203-213.
33. Detmar S.B., Muller M.J., Schornagel J.H., et al. Health related quality-of-life assessments and patient physician communication. JAMA 2002, 288:3027-3034.
34. Basch E., Artz D., Dulko D., et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 2005, 23:3552-3561.
35. Abernethy A.P., Zafar S.Y., Uronis H., et al. Validation of the patient care monitor (version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage 2010, 40:545-558.
36. Velikova G., Booth L., Smith A.B., et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 2004, 22:714-724.
37. Hilarius D.L., Kloeg P.H., Gundy C.M., et al. Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer 2008, 113:628-637.
38. Ruland C.M., Holte H.H., Roislien J., et al. Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial. J Am Med Inform Assoc 2010, 17:403-410.
39. Berry D.L., Blumenstein B.A., Halpenny B., et al. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 2011, 29:1029-1035.
40. Erharter A., Giesinger J., Kemmler G., et al. Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. J Pain Symptom Manage 2010, 39:219-229.
41. DuBenske L.L., Chih M.Y., Dinauer S., et al. Development and implementation of a clinician reporting system for advanced stage cancer: initial lessons learned. J Am Med Inform Assoc 2008, 15:679-686.
42. Basch E., Artz D., Iasonos A., et al. Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc 2007, 14:264-268.
43. Johnson G.D., Moore K., Fortner B. Baseline evaluation of the AIM Higher Initiative: establishing the mark from which to measure. Oncol Nurs Forum 2007, 34:729-734.
44. Berry D.L., Wilkie D.J., Thomas C.R., et al. Clinicians communicating with patients experiencing cancer pain. Cancer Invest 2003, 21:374-381.
45. Kennedy-Sheldon L., Hilaire D., Berry D.L. Provider verbal responses to patient distress cues during ambulatory oncology visits. Oncol Nurs Forum 2011, 38:369-375.
46. National Institutes of Health. State-of-the-Science conference on symptom management in cancer: pain, depression, and fatigue. 2002; Available at: (accessed March 12, 2011). http://consensus.nih.gov/2002/2002CancerPainDepressionFatigueSOS022Program.pdf.
47. Kallen MA, Yang D, Haas N. A technical solution to improving palliative and hospice care. Support Care Cancer [ePub ahead of print; doi: 10.1007/s00520-011-1086-z].
48. Kim N.Y., Richardson L., He W., et al. Patient preference to use a questionnaire varies according to attributes. Patient Educ Couns 2010, [ePub ahead of print; doi: 10.1016/j.pec.2010.08.018].
49. Bernstein R. US Hispanic population surpasses 45 million-now 15 percent of total. US Census Bureau 2008, US Department of Commerce, Washington, DC.
50. American community survey, R1620: percent of people 5 years and over who speak Spanish at home. Census Bureau of the Census 2007, US Census Bureau, US Department of Commerce, Washington, DC.
51. Cancer facts & figures for Hispanics/Latinos, 2009-2011 2009, American Cancer Society, American Cancer Society, Atlanta, GA, Available at:, (accessed October 30, 2010). http://www.cancer.org/acs/groups/content/@nho/documents/document/ffhispanicslatinos20092011.pdf.
52. Ramirez A.G., Suarez L., Chalela P., et al. Cancer risk factors among men of diverse Hispanic or Latino origins. Prev Med 2004, 39:263-269.
53. Zambrana R.E., Breen N., Fox S.A., et al. Use of cancer screening practices by Hispanic women: analyses by subgroup. Prev Med 1999, 29:466-477.
54. Savitz D.A., Janevic T.M., Engel S.M., et al. Ethnicity and gestational diabetes in New York City, 1995-2003. BJOG 2008, 115:969-978.
55. Borrell L.N., Crawford N.D. Disparities in self-reported hypertension in Hispanic subgroups, non-Hispanic black and non-Hispanic white adults: the national health interview survey. Ann Epidemiol 2008, 18:803-812.
56. Bowie J.V., Juon H.S., Cho J., et al. Factors associated with overweight and obesity among Mexican Americans and Central Americans: results from the 2001 California Health Interview Survey. Prev Chronic Dis 2007, 4:A10.
57. Oquendo M.A., Lizardi D., Greenwald S., et al. Rates of lifetime suicide attempt and rates of lifetime major depression in different ethnic groups in the United States. Acta Psychiatr Scand 2004, 110:446-451.
58. Alegria M., Canino G., Shrout P.E., et al. Prevalence of mental illness in immigrant and non-immigrant US Latino groups. Am J Psychiatry 2008, 165:359-369.
59. Friedman D.B., Hoffman-Goetz L. Assessment of cultural sensitivity of cancer information in ethnic print media. J Health Commun 2006, 11:425-447.
60. Resnicow K., Baranowski T., Ahluwalia J.S., et al. Cultural sensitivity in public health: defined and demystified. Ethn Dis 1999, 9:10-21.
61. Eversley R., Estrin D., Dibble S., et al. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum 2005, 32:250-256.
62. Ashing-Giwa K.T., Padilla G.V., Bohorquez D.E., et al. Understanding the breast cancer experience of Latina women. J Psychosoc Oncol 2006, 24:19-52.
63. Juarez G., Ferrell B., Borneman T. Influence of culture on cancer pain management in Hispanic patients. Cancer Pract 1998, 6:262-269.
64. Anderson K.O., Green C.R., Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain 2009, 10:1187-1204.
65. Anderson K.O., Mendoza T.R., Payne R., et al. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol 2004, 22:4918-4925.
66. Maly R.C., Liu Y., Leake B., et al. Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication. Breast Cancer Res Treat 2010, 119:707-716.
67. Wildes K.A., Miller A.R., de Majors S.S., et al. The religiosity/spirituality of Latina breast cancer survivors and influence on health-related quality of life. Psychooncology 2009, 18:831-840.
68. Taylor E.J. Spirituality, culture, and cancer care. Semin Oncol Nurs 2001, 17:197-205.
69. Ramirez A.G., Gallion K.J., Suarez L., et al. A national agenda for Latino cancer prevention and control. Cancer 2005, 103:2209-2215.
70. Crossing the quality chasm: a new health system for the 21st century 2001, Committee on Quality Health Care; Institute of Medicine, National Academy Press, Washington, DC.
71. Back A. Patient-physician communication in oncology: what does the evidence show?. Oncology (Williston Park) 2006, 20:67-74. discussion 77-68, 83.
72. Williams S.J. An overview of health care. Ambulatory care management 1998, 3-17. International Thompson Publishing, Albany. 3rd ed. S.J. Williams (Ed.).
73. Barton P.L. Understanding the US health services system 1999, Health Administration Press, Ann Arbor, MI.
74. Aligning payment policies with quality improvement. In: Crossing the quality chasm: a new health system for the 21st century 2001, Committee on Quality Health Care in America, Institute of Medicine, pp181-206.
75. Blendon R.J., Knox R.A., Brodie M., et al. Americans compare managed care, Medicare, and fee-for-service. J Am Health Policy 1994, 4:42-47.
76. Epstein R.M., Street R.L. Patient-centered communication in cancer care. promoting healing and reducing suffering. Institute NC, editor 2007, National Institutes of Health, Bethesda, MD.
77. The Joint Commission standards for hospitals 2008, The Joint Commission, The Joint Commission, Oakbrook Terrace, IL.
78. Oncology Nursing Society. Oncol Nurs Forum 2001, 28:441. Patients' bill of rights for quality cancer care.
79. American Hospital Association. The patient care partnership: understanding expectations, rights, and responsibilities. 2003. Available at: (accessed March 12, 2011). http://www.aha.org/aha/content/2003/pdf/pcp_english_030730.pdf.
80. House of Representatives. Patient protection and affordable care act. United States Congress, ed. HR 3590. Vol 2010.